more>SIPCD Snapshots

Invited Speakers



Yiyan Yang

Yi Yan Yang

Group Leader/Principle Investigator

Institute of Bioengineering and Nanotechnology

31 Biopolis Way, The Nanos, 138669, Singapore

 

Website:

http://www.ibn.a-star.edu.sg/research-areas-researcher.php

Email: yyyang@ibn.a-star.edu.sg


  Dr. Yi Yan Yang is a group leader and principle investigator with the Institute of Bioengineering and Nanotechnology (Agency for Science, Technology and Research, Singapore). She obtained Ph.D. degree in Chemical Engineering from Tsinghua University (China) in 1990. She has more than 230 peer-reviewed journal publications (e.g. Nat. Mater., Nat. Nanotech., Nat. Chem., Nat. Commun., Adv. Mater., Adv. Funct. Mater., Angew. Chem. Intl. Ed., Biomaterials, J. Control. Release, Adv. Healthcare Mater., Nanomedicine: Nanotechnology, Biology and Medicine) (H-index: 69), and 68 international patents filed/granted. Dr Yang has received many invitations to hold lectures and seminars in Singapore and overseas. In addition to her scientific contributions, Dr Yang has organized and chaired a number of symposiums and seminars over the years. In 2009, Singapore Women's Weekly Magazine awarded her the Great Women of Our Time Award, Science and Technology Category. In January 2016, she was elected to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows. She is an Associate Editor for Nanomedicine: Nanotechnology, Biology and Medicine, and on the Editorial Board for Advanced Healthcare Materials. Dr Yang's other professional activities include member of Material Research Society (MRS) in Singapore and MRS (USA), and member of American Chemical Society (ACS). Her research interests lie in macromolecular antimicrobial and anticancer therapeutics, nanomedicine, biomaterials, and drug/gene delivery.

 

Representative Publications

[1]     D. Park, Y. Y. Yang, et al, Addressing drug resistance in cancer with macromolecular chemotherapeutic agents. J. Am. Chem. Soc. 140 (2018) 4244-4252 (doi: 10.1021/jacs.7b11468)

[2]     W. Chin, Y.Y. Yang, et al, A macromolecular therapeutic approach to eradicate multidrug resistant bacterial infections while mitigating drug resistance onset. Nat. Commun. 9 (2018) 917. (doi: 10.1038/s41467-018-03325-6)

[3]     A. L. Z. Lee, Y. Y. Yang, et al, Injectable coacervate hydrogel for delivery of anticancer drug-loaded nanoparticles in vivo. ACS Appl. Mater. Interfaces 10 (2018) 13274-13282.

[4]     K. Fukushima, Y.Y. Yang, et al, Supramolecular high aspect ratio assemblies with strong antifungal activity. Nat. Commun. 4 (2013) 2861.

[5]     F. Nederberg, Y.Y. Yang, et al, Biodegradable nanostructures with selective lysis of microbial membranes. Nat. Chem. 3 (2011) 409-414.

[6]     L. H. Liu, Y.Y. Yang, et al, Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent. Nat. Nanotechn. 4 (2009) 457-463.

[7]     Y. Wang, Y. Y. Yang, et al, Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer. Nat. Mater. 5 (2006) 791-796.


Soochow University Biomedical Polymers Laboratory 
199 Ren-Ai Road, Suzhou Industrial Park, Suzhou 215123, China